The Use of Complementary and Alternative Medicine among Cancerous Children: A Survey at Ali Asghar Children's Hospital
,
Abstract
Survival rates for pediatric cancer patients have undergone rapid growth due to advancements in anticancer treatments. Despite these developments, cancer survivors continue to experience a range of persistent symptoms, including pain, fatigue, anxiety, depression, insomnia, and nausea/vomiting. Consequently, the use of complementary therapies has increased among this population as a means of alleviating these symptoms. This cross-sectional study involved 124 parents of children diagnosed with cancer and referred to Aliasghar Children’s Hospital in Tehran, selected via census sampling from January 2018 to January 2019. Data were collected using a validated and reliable questionnaire. Statistical analyses, including chi-square tests, Fisher’s exact test, and independent samples t-tests, were conducted to explore relationships between variables. A p value of < 0.05 was considered statistically significant, and data analysis was performed using SPSS version 25. Cronbach's alpha coefficient of this questionnaire was 0.85. Prior to diagnosis, 51.6% of patients reported using complementary medicine, which increased significantly to 77.4% after diagnosis. Herbal medicine emerged as the most commonly used form of complementary therapy. The primary motivation for using therapies was to manage chemotherapy side effects, reported by 83.3% of patients. The predominant barrier to the use of complementary medicine was insufficient knowledge regarding its benefits and risks. Notably, only one-third of mothers disclosed their children's use of integrative medicine to their physicians. The high prevalence of complementary medicine use among pediatric oncology patients underscores the necessity for healthcare providers to routinely inquire about such practices and educate patients about potential drug interactions. Additionally, the tendency for patients to conceal their use of complementary therapies from their healthcare providers warrants further attention and proactive engagement from clinicians.
Organization WH. Traditional, Complementary and Integrative Medicine: World Health Organization; 2018 [Available from: https://www.who.int/health-topics/traditional-complementary-and-integrative-medicine#tab=tab_1.
Steliarova-Foucher E, Colombet M, Ries LA, Moreno F, Dolya A, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol 2017;18:719-731.
Pöder U, Ljungman G, von Essen L. Parents’ perceptions of their children’s cancer-related symptoms during treatment: a prospective, longitudinal study. J Pain Symptom Manag 2010;40:661-670.
Ladas EJ. Integrative medicine in childhood cancer. J Altern Complement Med 2018;24:910-915.
Bishop FL, Prescott P, Chan YK, Saville J, von Elm E, et al. Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics 2010;125:768-776.
Haidar C, Jeha S. Drug interactions in childhood cancer. Lancet Oncol 2011;12:92-99.
Jacobs SS. Integrative therapy use for management of side effects and toxicities experienced by pediatric oncology patients. Children2014;1:424-440.
Seely D, Stempak D, Baruchel S. A strategy for controlling potential interactions between natural health products and chemotherapy: a review in pediatric oncology. J Pediatr Hematol Oncol 2007;29:32-47.
Sencer SF, Kelly KM. Complementary and alternative therapies in pediatric oncology. Pediatr Clin N 2007;54:1043-10460.
Roth M, Lin J, Kim M, Moody K. Pediatric oncologists’ views toward the use of complementary and alternative medicine in children with cancer. J Pediatr Hematol Oncol 2009;31:177-182.
Karalı Y, Demirkaya M, Sevinir B. Use of complementary and alternative medicine in children with cancer: effect on survival. Pediatr Hematol Oncol 2012;29:335-344.
Laengler A, Spix C, Seifert G, Gottschling S, Graf N, et al. Complementary and alternative treatment methods in children with cancer: a population-based retrospective survey on the prevalence of use in Germany. Eur J Cancer 2008;44:2233-2240.
Magi T, Kuehni CE, Torchetti L, Wengenroth L, Lüer S, et al. Use of complementary and alternative medicine in children with cancer: a study at a Swiss University Hospital. PloS One 2015;10:e0145787.
Singendonk M, Kaspers G-J, Naafs-Wilstra M, Meeteren AS-v, Loeffen J, et al. High prevalence of complementary and alternative medicine use in the Dutch pediatric oncology population: a multicenter survey. Eur J Pediatr 2013;172:31-37.
Al‐Qudimat MR, Rozmus CL, Farhan N. Family strategies for managing childhood cancer: using complementary and alternative medicine in Jordan. J Adv Nurs 2011;67:591-597.
Stub T, Quandt SA, Arcury TA, Sandberg JC, Kristoffersen AE. Attitudes and knowledge about direct and indirect risks among conventional and complementary health care providers in cancer care. BMC Complement Altern Med 2018;18:1-12.
O’Connor N, Graham D, O’Meara A, Devins M, Jennings V, et al. The use of complementary and alternative medicine by Irish pediatric cancer patients. J Pediatr Hematol Oncol 2013;35:537-342.
Vlieger AM, van Vliet M, Jong MC. Attitudes toward complementary and alternative medicine: a national survey among paediatricians in the Netherlands. Eur J Pediatr 2011;170:619-624.
Bordbar M, Kamfiroozi R, Fakhimi N, Jaafari Z, Zarei T, et al. Complementary and alternative medicine in pediatric oncology patients in South of Iran. Iran J Pediatr Hematol Oncol 2016;6:216-227.
Ben-Arye E, Frenkel M, Klein A, Scharf M. Attitudes toward integration of complementary and alternative medicine in primary care: perspectives of patients, physicians and complementary practitioners. Patient Educ Couns 2008;70:395-402.
Dadgari A, Bagheri I, Salmani N, Mirakhor M. Mothers’ attitudes toward the use of complementary and alternative medicine in children with cancer. Int J Cancer Manag 2020;13.
Gottschling S, Meyer S, Längler A, Scharifi G, Ebinger F, et al. Differences in use of complementary and alternative medicine between children and adolescents with cancer in Germany: a population based survey. Pediatric Blood Cancer 2014;61:488-492.
Lüthi E, Diezi M, Danon N, Dubois J, Pasquier J, et al. Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment. BMC Complement Med Ther 2021;21:1-11.
Fesharakinia A, Abedini M. Prevalence of using complementary and alternative medicine in children and its related factors in east Iran. Iran J Pediatr 2014;24:111.
Yeon G-M, Nam SO. The use of complementary and alternative medicine in children with common neurologic diseases. Korean J Pediatr 2016;59:313.
Friedman T, Slayton WB, Allen LS, Pollock BH, Dumont-Driscoll M, et al. Use of alternative therapies for children with cancer. Pediatrics 1997;100:e1.
Stub T, Kristoffersen AE, Overvåg G, Jong MC. An integrative review on the information and communication needs of parents of children with cancer regarding the use of complementary and alternative medicine. BMC complement Med Ther 2020;20:1-19.
Ben‐Arye E, Samuels N, Goldstein LH, Mutafoglu K, Omran S, et al. Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals. Cancer 2016;122:598-610.
Diorio C, Salena K, Ladas EJ, Lam CG, Afungcwhi GM, et al. Traditional and complementary medicine used with curative intent in childhood cancer: a systematic review. Pediatr Blood Cancer 2017;64:e26501.
| Issue | Vol 10, No 1, 2025 -In Press- | |
| Section | Research Article(s) | |
| Keywords | ||
| Alternative medicine Cancer Children Complementary medicine Pediatric Neoplasm | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
